|
Published: April 2016
|
Report Code: LS10480
|
Available Format:
|
Pages: 121
|
|
Category : Medical Devices
|
|||
The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% during 2016-2022. The Strips/Dipsticks segment dominated the global market in 2015. The global Female fertility and pregnancy rapid test market is witnessing high growth, due to growing female geriatric population and increasing prevalence of infertility due to changes in lifestyle, increase in PCOS cases, and growing obese population. Also, the growing awareness about the easy to use at home diagnostic devices is further propelling the growth of the market.
The prevalence of gynaecological problems, such abnormal uterine bleeding is increasing. The American College of Obstetricians and Gynaecologists stated that bleeding between periods, after sex, and after menopause is considered abnormal. In addition it also stated that menstrual cycles longer that 35 days and shorter than 21 days, and lack of periods in 3-6 months is also considered abnormal. Abnormal uterine bleeding occurs, as a result of uterine malformations, sub mucosal myoma, polyps, which are increasing the infertility cases, necessitating the need for hormonal test, thus promoting the growth of the global female fertility and pregnancy rapid test market.
The increasing female aging population is propelling the growth of the global Female fertility and pregnancy rapid test market. As reported by UN DESA (United Nation Department of Economic and Social Affairs) in the year 2013, the elder population is predominantly female. As women tend to live longer than men, while older women have outnumbered older men almost everywhere in the world. It further reported that in the year 2013, globally, there were 85 men per 100 women in the age group 60 years or plus; and 61 men per 100 women in the age group 80 years or plus. The elderly population is more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the demand of the global female fertility and pregnancy rapid test market. Aging in females leads to changes in hormones leading to irregular menses, which contributes to the demand for hormonal tests thus leading to the growth of the market.
The increasing awareness about advantageous features possessed by these at home pregnancy and fertility rapid test attract the patients around the world to opt for such easy to use devices instead of going for a lab based test. At home fertility and pregnancy rapid test are time saving, comparatively economical, helps maintain privacy and can be used by the females at the comfort of their home; thus, generating a high demand for at home diagnostic devices leading to the growth of the global female fertility and pregnancy rapid test market.
The restraints impacting the growth of the global female fertility and pregnancy rapid test market include the availability of alternative diagnostic test such as blood test; saliva test and reagent based laboratory test are inhibiting the growth of the market. Furthermore, the high cost of midstream, in comparison to strips/dipsticks and cassettes/cards make them less affordable by the patient pool. The patients suffer from fertility problems check their FSH, LH or HCG levels using strips/dipsticks or cassettes/cards as first line of diagnosis as they are cheaper in comparison to midstream which makes midstream not affordable by everyone in developing countries, thus affecting the growth of the market.
The key companies operating in the global female fertility and pregnancy rapid test market include Alere Inc., Atlas Medical, Diagnostic Automation/Cortez Diagnostics Inc., BioMerieux SA, SA Scientific, Church & Dwight Co., Inc.., Nantong Egens Biotechnology Co. Ltd., and Gemc Technology Group Co., Ltd.
